Older adults with HIV are at significantly higher risk for cutaneous malignancies when compared with younger patients with HIV.

Toxoplasmosis and MDD were among several preexisting comorbidities associated with the development of neurocognitive disorders in patients with HIV infection.

Severe mpox and long-term sequelae such as severe scarring were more likely to occur among HIV-positive patients with detectable viral loads and low CD4 counts.

Gilead plans to go straight to Phase III studies for once-yearly lenacapavir, while GSK and Viiv will push forward with their ...

The company is planning a Phase 3 trial for the new formulation of lenacapavir, Stat reports. Other pharma and technology news is on microplastics and the spread of antibiotic-resistant superbugs; a ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Let’s take your partner’s HIV status out of the equation for a moment. You’re looking at a person who has a concerning temper, refuses to admit faults (and, therefore, probably refuses to work on them ...

HIV incidence in sub-Saharan Africa has declined substantially, according to both UNAIDS estimates and empirical data pulled ...

Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

To reduce care disparities and prevent them from exacerbating among people living with HIV who have long COVID, education and ...

The Scottish Brain Sciences team are on the cusp of medical breakthroughs which will ‘cure’ the world’s most feared disease. They talk to ...